IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TIFFANY MARIE BOWSER

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1427645597
CMS profile
10628313
Location
KNOX, IN

General Payments · PY2021–2024

$3,606.94

  • Reported across 187 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,139.34

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family IN All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,139.34 52

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $288.35 14
ABBVIE INC. $154.66 7
Supernus Pharmaceuticals, Inc. $114.18 1
ITI, Inc. $101.68 5
Lilly USA, LLC $80.35 4
Axsome Therapeutics, Inc. $76.28 3
Novo Nordisk AS $66.90 4
Corium, Inc. $63.60 4
SHIELD THERAPEUTICS INC $42.59 1
Boehringer Ingelheim Pharmaceuticals, Inc. $35.52 2
NOVARTIS PHARMACEUTICALS CORPORATION $19.74 1
Bayer HealthCare Pharmaceuticals Inc. $19.10 1
Otsuka America Pharmaceutical, Inc. $18.91 1
OWP Pharmaceuticals, Inc. $15.51 1
Lundbeck LLC $15.36 1
GlaxoSmithKline, LLC. $13.31 1
Almatica Pharma Inc. $13.30 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $443.51 25
PY2022 $846.97 48
PY2023 $1,177.12 62
PY2024 $1,139.34 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $26.41 01/31/2024 Food and Beverage Undisputed 01/23/2026 1106808620 CMS
ABBVIE INC. $11.08 01/31/2024 Food and Beverage Undisputed 01/23/2026 1106808622 CMS
ABBVIE INC. $16.15 05/08/2024 Food and Beverage Undisputed 01/23/2026 1106808624 CMS
ABBVIE INC. $30.66 05/23/2024 Food and Beverage Undisputed 01/23/2026 1106808626 CMS
ABBVIE INC. $23.71 06/24/2024 Food and Beverage Undisputed 01/23/2026 1106808628 CMS
ABBVIE INC. $23.23 07/17/2024 Food and Beverage Undisputed 01/23/2026 1106808630 CMS
ABBVIE INC. $23.42 08/28/2024 Food and Beverage Undisputed 01/23/2026 1106808632 CMS
Almatica Pharma LLC $13.30 09/05/2024 Food and Beverage Undisputed 01/23/2026 1137587965 CMS
AstraZeneca Pharmaceuticals LP $76.12 01/30/2024 Food and Beverage Undisputed 01/23/2026 1104305592 CMS
AstraZeneca Pharmaceuticals LP $18.41 02/14/2024 Food and Beverage Undisputed 01/23/2026 1105392350 CMS
AstraZeneca Pharmaceuticals LP $14.91 03/26/2024 Food and Beverage Undisputed 01/23/2026 1104255507 CMS
AstraZeneca Pharmaceuticals LP $13.08 05/14/2024 Food and Beverage Undisputed 01/23/2026 1104337892 CMS
AstraZeneca Pharmaceuticals LP $16.08 06/12/2024 Food and Beverage Undisputed 01/23/2026 1105556472 CMS
AstraZeneca Pharmaceuticals LP $21.88 06/26/2024 Food and Beverage Undisputed 01/23/2026 1105531552 CMS
AstraZeneca Pharmaceuticals LP $16.95 08/15/2024 Food and Beverage Undisputed 01/23/2026 1104407527 CMS
AstraZeneca Pharmaceuticals LP $19.11 08/23/2024 Food and Beverage Undisputed 01/23/2026 1104319958 CMS
AstraZeneca Pharmaceuticals LP $14.20 09/18/2024 Food and Beverage Undisputed 01/23/2026 1105492127 CMS
AstraZeneca Pharmaceuticals LP $13.49 09/24/2024 Food and Beverage Undisputed 01/23/2026 1105886879 CMS
AstraZeneca Pharmaceuticals LP $16.46 09/30/2024 Food and Beverage Undisputed 01/23/2026 1105323739 CMS
AstraZeneca Pharmaceuticals LP $13.32 10/09/2024 Food and Beverage Undisputed 01/23/2026 1104729861 CMS
AstraZeneca Pharmaceuticals LP $15.78 10/15/2024 Food and Beverage Undisputed 01/23/2026 1104494970 CMS
AstraZeneca Pharmaceuticals LP $18.56 10/18/2024 Food and Beverage Undisputed 01/23/2026 1105430565 CMS
Axsome Therapeutics, Inc. $33.42 01/04/2024 Food and Beverage Undisputed 01/23/2026 1148416023 CMS
Axsome Therapeutics, Inc. $26.87 02/06/2024 Food and Beverage Undisputed 01/23/2026 1148416025 CMS
Axsome Therapeutics, Inc. $15.99 10/07/2024 Food and Beverage Undisputed 01/23/2026 1148416027 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.10 12/13/2024 Food and Beverage Undisputed 01/23/2026 1086349231 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.75 10/16/2024 Food and Beverage Undisputed 01/23/2026 1118006467 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.77 11/14/2024 Food and Beverage Undisputed 01/23/2026 1118006469 CMS
Corium, LLC $13.33 01/22/2024 Food and Beverage Undisputed 01/23/2026 1100116612 CMS
Corium, LLC $11.18 06/04/2024 Food and Beverage Undisputed 01/23/2026 1100156997 CMS
Corium, LLC $19.02 08/22/2024 Food and Beverage Undisputed 01/23/2026 1100174966 CMS
Corium, LLC $20.07 09/16/2024 Food and Beverage Undisputed 01/23/2026 1100177932 CMS
GlaxoSmithKline, LLC. $13.31 08/17/2024 Food and Beverage Undisputed 01/23/2026 1116102339 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.99 05/29/2024 Food and Beverage Undisputed 01/23/2026 1143383083 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.16 07/02/2024 Food and Beverage Undisputed 01/23/2026 1143383087 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.71 08/06/2024 Food and Beverage Undisputed 01/23/2026 1143383091 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.35 09/12/2024 Food and Beverage Undisputed 01/23/2026 1143383094 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.47 12/14/2024 Food and Beverage Undisputed 01/23/2026 1143383098 CMS
Lilly USA, LLC $17.63 06/19/2024 Food and Beverage Undisputed 01/23/2026 1135965284 CMS
Lilly USA, LLC $19.32 09/20/2024 Food and Beverage Undisputed 01/23/2026 1135990304 CMS
Lilly USA, LLC $22.29 10/11/2024 Food and Beverage Undisputed 01/23/2026 1135965286 CMS
Lilly USA, LLC $21.11 11/19/2024 Food and Beverage Undisputed 01/23/2026 1135972434 CMS
Lundbeck LLC $15.36 02/12/2024 Food and Beverage Undisputed 01/23/2026 1145997353 CMS
Novartis Pharmaceuticals Corporation $19.74 07/24/2024 Food and Beverage Undisputed 01/23/2026 1086664425 CMS
Novo Nordisk Inc $15.88 01/24/2024 Food and Beverage Undisputed 01/23/2026 1100596061 CMS
Novo Nordisk Inc $13.76 06/06/2024 Food and Beverage Undisputed 01/23/2026 1100504173 CMS
Novo Nordisk Inc $20.43 10/23/2024 Food and Beverage Undisputed 01/23/2026 1100583974 CMS
Novo Nordisk Inc $16.83 12/17/2024 Food and Beverage Undisputed 01/23/2026 1100297277 CMS
Otsuka America Pharmaceutical, Inc. $18.91 02/01/2024 Food and Beverage Undisputed 01/23/2026 1119030914 CMS
OWP Pharmaceuticals, Inc. $15.51 11/07/2024 Food and Beverage Undisputed 01/23/2026 1150025976 CMS
SHIELD THERAPEUTICS INC $42.59 07/30/2024 Food and Beverage Undisputed 01/23/2026 1150139815 CMS
Supernus Pharmaceuticals, Inc. $114.18 01/25/2024 Food and Beverage Undisputed 01/23/2026 1147882966 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.